Penile Extender Before and After: The Length-Only Truth in 2026

Introduction: Why “Before and After” Searches Deserve an Honest Answer

Men who search for penile extender before-and-after results are rarely looking for hype. Many are accomplished professionals between 25 and 54 who have built careers on research, due diligence, and measurable outcomes. Before they commit months of daily effort to a traction device, they want to know whether the investment will actually pay off.

This article offers a clinical-data walkthrough of what extenders deliver, who was actually studied in the trials, and why girth is often the variable these men are really trying to solve.

The core tension is simple. Penile extenders are a real, peer-reviewed length intervention. They are also a length-only intervention, tested mostly on men with medical conditions rather than healthy men pursuing cosmetic gains. The sections below separate marketing statistics from clinical reality, then point toward the option that has been clinically studied for girth.

What the “32%” Statistic Actually Means

Nearly every extender product page cites the same number: a 32% increase in length. That figure comes from Gontero et al., a 2009 study conducted at the University of Turin, and it has become the most recycled statistic in extender marketing.

The number gets repeated across affiliate sites because it is large and memorable, and because it carries the credibility of a university hospital. What rarely travels with it is the context: who was tested, what was measured, and what did not change.

The Study Design and Who Was Actually Tested

Participants wore the Andro-Penis extender 4 to 6 hours daily for 6 months. That is a demanding protocol, closer to a part-time job than a casual wellness habit.

The study population also matters. It skewed toward men with shortened or compromised penile length rather than healthy men seeking cosmetic enlargement. Consumer-facing content rarely discloses this mismatch, even though it shapes how the results should be interpreted.

The Real Numbers: Flaccid, Stretched, and Erect Length

The headline results were:

  • Flaccid length: increased by up to 32%
  • Stretched length: increased by 18%

Marketing tends to blur an important distinction. Flaccid and stretched measurements are not the same as erect length. Erect length gains from traction are typically smaller and less consistent than flaccid or stretched gains.

In practical terms, a man with a stretched length of about 13 cm (roughly 5.1 inches) would see about 2.3 cm (under one inch) from an 18% gain. That figure applies under ideal trial conditions, and it describes stretched length rather than erect size. A “32%” claim sounds transformative. A centimeter or two of stretched length is a modest outcome.

The Satisfaction Score Gap: Length vs. Girth

The most revealing data in the Gontero study is the satisfaction scoring, measured on a 3-point scale:

Measure Satisfaction Score (out of 3)
Flaccid length 2.31
Erect length 2.37
Girth 1.1

The study explicitly reported no significant increase in penile girth. The satisfaction gap is the clearest clinical evidence that extenders can satisfy length goals but fail girth goals. This is the first signal that many men are using a length tool to solve a problem that may not be about length.

Beyond Gontero: What Other Clinical Trials Show

Relying on a single study from 2009 is scientifically thin. A complete picture requires newer, independent data, and the broader literature generally points to more modest results than marketing suggests.

Nikoobakht (2011): Small Sample, Modest Gains

In a study by Nikoobakht and colleagues, 21 men used a traction device 4 to 6 hours per day for 3 months. The mean stretched-length increase was only about 1 cm.

The study had no control group, which is a significant limitation. Without a comparison group, researchers cannot fully separate the device’s effect from measurement variation, natural fluctuation, or placebo-driven reporting.

Moncada et al. (2019): A Systematic Review Calls for Better Evidence

A 2019 systematic review by Moncada and colleagues concluded that traction therapy may produce modest length gains. It also found that the overall quality of the evidence was low, citing:

  • Small sample sizes
  • Short follow-up periods
  • Highly inconsistent protocols across trials

In effect, the clinical community has acknowledged that the extender evidence base is far from settled.

RestoreX and the Modern Device Era

Device design has improved. Older devices required 4 to 8 hours of daily wear. The FDA-cleared RestoreX device uses sessions of 30 to 90 minutes per day.

In a randomized controlled trial published in the Journal of Urology, RestoreX users saw a median stretched length increase of 1.6 cm at 6 months, compared with 0.3 to 0.7 cm in controls. That is a meaningful step forward in evidence quality.

These trials, however, were conducted largely in post-prostatectomy and Peyronie’s disease populations, which reinforces the population-mismatch issue. Modern devices deserve credit for reducing the daily burden, but the absolute gains remain modest and still apply only to length.

The Population Mismatch Nobody Talks About

Nearly every major extender trial has recruited men with Peyronie’s disease (a condition involving penile curvature and scar tissue) or post-surgical length loss after procedures such as prostatectomy. These trials did not focus on healthy men seeking cosmetic enlargement.

There is a sound clinical reason for this. In these patients, traction therapy aims to restore lost length or function, or to remodel scar tissue. Those are therapeutic goals. Most men searching for “before and after” results have a cosmetic goal.

Results from a therapeutic population may not carry over to a healthy man’s anatomy. Tissue that has been shortened by disease or surgery may respond differently than healthy tissue. Most competing content glosses over this credibility gap.

Why This Matters for Expectations

A man without underlying tissue shortening may see smaller relative gains than trial participants. When applying published percentages to a cosmetic-only goal, he should reasonably adjust those figures downward. The trial averages describe a recovery from a deficit, which is different from enlargement beyond a healthy baseline.

The Real-World Compliance Problem

Even with realistic expectations, another barrier remains. Extender results depend directly on hours worn, and most men cannot sustain clinical-trial levels of compliance.

0.38 cm Gained Per Additional Hour of Daily Wear

Multivariate analysis of traction outcomes has found that length gain is directly proportional to daily wear time, at roughly 0.38 cm per additional hour of daily use.

The math is sobering. If a man drops from the trial standard of 6 hours per day to a more realistic 2 to 3 hours, he reduces his expected result by roughly 1.1 to 1.5 cm. For a device whose best-case outcome is often 1 to 2.5 cm, that reduction can remove most of the benefit. This helps explain why real-world outcomes often fall short of published averages.

The 4-6 Hour Daily Reality Check

For a working professional, 4 to 6 hours of daily device wear has to fit around client meetings, business travel, workouts, and family time, every day for months. Few executives, attorneys, physicians, or founders can wear a traction device for a large share of their waking hours without disruption.

Newer devices reduce this burden, but they still require consistent, months-long commitment. For many extender users, compliance limits results more than biology does.

Why Clinical Trial Results Rarely Translate to Home Use

Trial participants benefit from:

  • Regular clinical monitoring
  • Structured follow-up appointments
  • Built-in accountability and motivation

Home users usually lack all three. Published averages are best treated as a ceiling, not a guarantee.

The Girth Gap Every Study Reports

Virtually no clinical trial of penile extenders shows meaningful girth improvement.

A 2016 review in the Journal of Sexual Medicine stated that overall benefits are confined to length, ranging from 0.1 to 1.7 cm, while data on girth show “no improvements or inconsistent results.”

The reason is biomechanical. Traction pulls tissue along a single axis. It can encourage gradual elongation, but it does not meaningfully expand circumference. No amount of compliance changes that.

Satisfaction Scores Confirm the Length-Only Verdict

The Gontero girth satisfaction score of 1.1 out of 3 remains the clearest quantified proof. It matters because multiple studies and surveys indicate that partners often rate girth as equally or more important than length for sexual satisfaction.

The perception data adds another layer:

Taken together, these findings suggest that many men may be optimizing the wrong variable. Months spent chasing length may never address the concern that drives their lack of confidence.

Before and After: What to Realistically Expect From an Extender

Based on the clinical literature, the realistic picture looks like this:

  • Length: approximately 0.5 to 1 inch (1 to 2.5 cm) in stretched or flaccid length, with 4 to 6 hours of daily use over 3 to 6 months
  • Modern devices: RestoreX and similar devices can produce comparable gains with 30 to 90 minute daily sessions
  • Erect length: gains are typically smaller and less consistent than flaccid or stretched gains
  • Girth: essentially no change, regardless of device, duration, or compliance

If the Actual Goal Is Girth, Not Length

For men whose confidence concerns are girth-driven, whether because of partner feedback or their own self-perception, months of traction therapy will not address the goal, no matter how consistently they wear the device. A different tool is required, and one has been studied clinically for this purpose.

Filler Phalloplasty: The Clinically Validated Girth Alternative

Non-surgical hyaluronic acid (HA) filler injections, often called filler phalloplasty, have produced measurable girth results. A retrospective study of 155 men presented in the Journal of Sexual Medicine found:

  • An average 0.633 cm girth increase per treatment
  • Patients receiving 4 or more treatments averaged a 2.95 cm increase in circumference

Key differences from extenders include:

  • Immediacy: results are visible the same day, rather than after months of uncertain compliance.
  • Reversibility: HA filler can be dissolved with hyaluronidase if a patient is dissatisfied, which is not possible with surgical approaches.
  • Safety: a retrospective review reported low complication rates, with no reported cases of erectile dysfunction or sensation loss. The issues noted were a small number of injection-site infections linked to non-compliance with aftercare and a few granulomas that resolved.
  • Longevity: results typically last 18 to 24 months. The approach requires periodic maintenance rather than daily wear.

What the Procedure Looks Like in Practice

At Stoller Medical Group, filler phalloplasty is performed as a non-surgical, outpatient procedure completed in under one hour using Belefil®, a medical-grade HA-based filler. The procedure involves no incisions and no general anesthesia.

  • Recovery: most patients return to normal activity in about 10 days, and sexual activity typically resumes within 7 to 10 days.
  • Staged treatment: the practice uses multiple sessions to build symmetry and natural-looking results rather than one dramatic change. Follow-up is typically scheduled 2 to 3 months after the initial treatment.
  • Glans enhancement: men who want comprehensive, proportional improvement can have the glans treated during the same session.

The practice does not offer surgical penile lengthening because of its higher associated risks. That decision reflects a safety-first approach to treatment selection.

Understanding the Investment

Stoller Medical Group’s treatment pricing starts at $7,500, with the total cost depending on the patient’s desired results. Pricing is structured by syringe, and most men require a minimum of 10 syringes, with an average of 15 syringes during their first procedure.

That investment should be weighed against the alternative: months of daily device wear with results that depend on compliance and no girth benefit. A free consultation allows each patient to receive an individualized syringe count and treatment plan based on his anatomy and goals.

Conclusion: Matching the Right Solution to the Right Goal

The clinical verdict is clear. Penile extenders can produce modest, real length gains of roughly 1 to 2.5 cm in motivated, highly compliant users. Those gains have been documented mainly in men with Peyronie’s disease or post-surgical length loss.

Girth gains from traction devices are consistently negligible or statistically insignificant across every major study reviewed.

The more useful question for many men is whether their goal is length, or whether it is the confidence that often comes from girth and proportion. For men whose goal has been girth all along, filler phalloplasty offers an evidence-supported, immediate, and reversible path.

Ready to Explore a Clinically Proven Girth Solution?

Men who have spent years quietly lacking confidence, or who never believed a real solution existed, can schedule a free, discreet consultation with Stoller Medical Group to discuss their personal goals.

Dr. Roy B. Stoller, a board-certified physician with more than 25 years in aesthetic and restorative medicine, leads a practice that has performed over 15,000 enlargement procedures. Patients can choose from five locations:

  • Manhattan, NY: 515 Madison Avenue, Suite 1205
  • Long Island, NY: 366 N Broadway, Suite LE2, Jericho
  • Albany, NY: 1202 Troy Schenectady Road, Building No. 2, Latham
  • Pennsylvania: 1212 Baltimore Pike, Chadds Ford
  • Minnesota: 2121 Cliff Drive, Suite 210, Eagan

Every consultation is confidential and safety-focused, with an emphasis on natural-looking results that are visible the same day. The first step is a private conversation with a team that treats male enhancement as medicine.